Endothelin, PAF and thromboxane A2 in allergic pulmonary hyperreactivity in mice

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 76, Issue 5, 2007, Pages 299-308

  Richter, Martin ^a   Cloutier, Solange ^a   Sirois, Pierre ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 9ALPHA,11ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; CARBACHOL; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; L 654 664; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; OVALBUMIN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BRONCHIAL HYPERREACTIVITY; CARBACHOL; ENDOTHELIN-1; ENDOTHELINS; MALE; MICE; MICE, INBRED BALB C; OLIGOPEPTIDES; OVALBUMIN; PEPTIDE FRAGMENTS; PHOSPHOLIPID ETHERS; PIPERIDINES; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; RECEPTOR, ENDOTHELIN B; THROMBOXANE A2;

MUS;

EID: 34249100542     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.02.004     Document Type: Article

References (47)

1. Djukanovic R., Roche W.R., Wilson J.W., Wesley C.R.W., Twentyman O.P., Howarth P.H., and Holgate S.T. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142 (1990) 434-457
2. Barnes P.J. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J. Allergy Clin. Immunol. 83 (1989) 1013-1026
3. Chung K.F., Aizawa H., Becker A.B., Frick O., Gold W.M., and Nadel J.A. Inhibition of antigen-induced airway hyperresponsiveness by a tromboxane synthetase inhibitor (OKY-046) in allergic dogs. Am. Rev. Respir. Dis. 134 (1986) 258-261
4. Lee T.C., Lenihan D.J., Malone B., Ruddy L.L., and Wasserman S.I. Increased synthesis of platelet activating factor in activated human eosinophils. J. Biol. Chem. 259 (1984) 5526-5530
5. Jorg A., Henderson W.R., Murphy R.C., and Klebanoff S.J. Leukotriene generation by eosinophils. J. Exp. Med. 155 (1982) 390-402
6. Mullol J., Chowdhury B.A., White M.V., Ohkubo K., Rieves R.D., Baraniuk J., Hausfeld J.N., Shelhamer J.H., and Kaliner M.A. Endothelin in human nasal mucosa. Am. J. Respir. Cell. Mol. Biol. 8 (1993) 393-402
7. Riccio M.M., Reynolds C.J., Hay D.W., and Proud D. Effects of intranasal administration of endothelin-1 to allergic and nonallergic individuals. Am J. Respir. Crit. Care Med. 152 (1995) 1757-1764
8. Filep J.G., Sirois M.G., Rousseau A., Fournier A., and Sirois P. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br. J. Pharmacol. 104 (1991) 797-804
9. Helset E., Kjaeve J., and Hauge A. Endothelin-1-induced increases in microvascular permeability in isolated, perfused rat lungs requires leukocytes and plasma. Circ. Shock. 39 (1993) 15-20
10. Noveral J.P., Rosenberg S.M., Anbar R.A., Pawlowski N.A., and Grunstein M.M. Role of endothelin-1 in regulating proliferation of cultured rabbit airway smooth muscle cells. Am. J. Physiol. 263 (1992) L317-L324
11. Panettieri Jr. R.A., Goldie R.G., Rigby P.J., Esztherhas A.J., and Hay D.W. Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon. Br. J. Pharmacol. 118 (1996) 191-197
12. Stewart A.G., Grigoriadis G., and Harris T. Mitogenic actions of endothelin-1 and epidermal growth factor in cultured airway smooth muscle. Clin. Exp. Pharmacol. Physiol. 21 (1994) 277-285
13. Tomlinson P.R., Wilson J.W., and Stewart A.G. Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br. J. Pharmacol. 111 (1994) 641-647
14. Fernandes L.B., Henry P.J., Rigby P.J., and Goldie R.G. Endothelin (ETB) receptor-activated potentiation of cholinergic nerve-mediated contraction in human bronchus. Br. J. Pharmacol. 118 (1996) 1873-1874
15. Henry P.J., and Goldie R.G. Potentiation by endothelin-1 of cholinergic nerve-mediated contractions in mouse trachea via activation of ETB receptors. Br. J. Pharmacol. 114 (1995) 563-569
16. Chung K.F., Aizawa H., Leikauf G.D., Ueki I.F., Evans T.W., and Nadel J.A. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J. Pharmacol. Exp. Ther. 236 (1986) 580-584
17. Sanjar S., Aoki S., Boubekeur K., Chapman I.D., Smith D., Kings M.A., and Morley J. Eosinophil accumulation in pulmonary airways of guinea-pigs induces by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs. Br. J. Pharmacol. 99 (1990) 267-272
18. Murlas C.G., Murphy T.P., and Chodimella V. Ozone-induced mucosa-linked airway muscle hyperresponsiveness in the guinea-pig. J. Appl. Physiol. 69 (1990) 7-13
19. Buckner C.K., Sonsiridej V., Dick E.C., and Busse W.V. In vivo and in vitro studies of the use of the guinea pig as a model for virus-provoked airway hyperreactivity. Am. Rev. Respir. Dis. 132 (1985) 305-310
20. Konzett H., and Rössler R. Versuchsanordnung zu untersuchungen an der bronchial muskulatur. Naunyn-Schmeidebergs Arch. Pharmacol. 195 (1940) 71-75
21. Kung T.T., Jones H., Adams G.K., Umland S.P., Kreutner W., Egan R.W., Chapman R.W., and Watnick A.S. Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy Immunol. 105 (1994) 83-90
22. Spicer B.A., Baker R.C., Hatt P.A., Laycock S.M., and Smith H. The effects of drugs on Sephadex-induced eosinophilia and lung hyper-responsiveness in the rat. Br. J. Pharmacol. 101 (1990) 821-828
23. 2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor, in: A.R. Liss (Ed.), Prostaglandins in Clinical Research: Cardiovascular System, 1989, pp. 579-583.
24. Daniel E.E., and O'Byrne P. Effect of inflammatory mediators on airway nerves and muscle. Am. Rev. Respir. Dis. 143 (1991) S3-S5
25. 2 in bronchial hyperresponsiveness but not lung inflammation induced by bacterial lipopolysaccharide in guinea pigs. Eur. J. Pharmacol. 231 (1993) 13-21
26. 2) receptor antagonist (S-1452) on the antigen-induced bronchoconstriction and airway hyperresponsiveness in guinea pigs. Prostaglandin Leukotr. Essent. Fatty Acids 48 (1993) 343-349
27. Abraham W.M., Stevenson J.S., and Garrido R. A leukotriene and thromboxane inhibitor (Sch 37224) blocks antigen-induced immediate and late responses and airway hyperresponsiveness in allergic cheep. J. Pharmacol. Exp. Ther. 427 (1988) 1004-1011
28. Aizawa H., Chung K.F., Leikauf G.D., Ueki I.F., Bethel R.A., O'Byrne P.M., Hirose T., and Nadel J.A. Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs. J. Appl. Physiol. 59 (1985) 1918-1923
29. 2 synthetase inhibitor (OKY-046) on airway hyperresponsiveness induced by ozone exposure in beagles. Jpn. J. Allergol. 34 (1985) 469-473
30. 4 induces airway hyperresponsiveness in dogs. J. Appl. Physiol. 59 (1985) 1941-1946
31. Longphre M., Zhang L.Y., Paquette N., and Kleeberger S.R. PAF-induced airways hyperreactivity is modulated by mast cells in mice. Am. J. Resp. Cell Mol. Biol. 14 (1996) 461-469
32. Morooka S., Uchida M., and Imanishi N. Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine. Br. J. Pharmacol. 105 (1992) 756-762
33. Havill A.M., Van Valen R.G., and Handley D.A. Prevention on non-specific airway hyperreactivity after allergen challenge in guinea-pigs by a PAF receptor antagonist SDZ 64-412. Br. J. Pharmacol. 99 (1990) 396-400
34. Martin T.R., Takeishi T., Katz H.R., Austen K.F., Drazen J.M., and Galli S.J. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J. Clin. Invest. 91 (1993) 1176-1182
35. Kips J.C., Tavernier J.H., Joos G.F., Peleman R.A., and Pauwels R.A. The potential role of tumour necrosis factor α in asthma. Clin. Exp. Allergy 23 (1993) 247-250
36. Thomas P.S. Tumor necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol. Cell. Biol. 79 (2001) 132-140
37. Sekizawa K., Caughey G.H., Lazarus S.C., Gold W.M., and Nadel J.A. J.A. Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs,. J. Clin. Invest. 83 (1989) 175-179
38. Finnerty J.P., Twentyman O.P., Harris A., Palmer J.B., and Holgate S.T. Effect of GR32191, a potent thromboxane receptor antagonist, on exercise induced bronchoconstriction in asthma. Thorax 46 (1991) 190-192
39. Henig N.R., Aitken M.L., Liu M.C., Yu A.S., and Henderson W.R. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. Am. J. Respir. Crit. Care Med. 162 (2000) 523-527
40. Spence D.P., Johnston S.L., Calverly P.M., Dhillon P., Higgins C., Ramhamadany E., Turner S., Winning A., Winter J., and Holgate S.T. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am. J. Respir. Crit. Care Med. 149 (1994) 1142-1148
41. M.C. Toffoli, B.H. Gabra, C.F.P. Teixeira, P. Sirois, S. Jancar, Endothelins mediate neutrophil activation, proMMP-9 release and endothelial cell detachment, Inflammation, e-publication, January 13, 2007.
42. Fujitani Y., Trifilieff A., Tsuyuki S., Coyle A.J., and Bertrand C. Endothelin receptor antagonists inhibit antigen-induced lung inflammation in mice. Am. J. Respir. Crit. Care Med. 155 (1997) 1890-1894
43. Carr M.J., Goldie R.G., and Henry P.J. Influence of respiratory tract viral infection on endothelin-1-induced potentiation of cholinergic nerve-mediated contraction in mouse trachea. Br. J. Pharmacol. 119 (1996) 891-898
44. Goldie R.G., Henry P.J., Rigby P.J., and Knott P.G. Influence of respiratory tract viral infection on endothelin-1-induced modulation of cholinergic nerve-mediated contractions in murine airway smooth muscle. J. Cardiovasc. Pharmacol. 31 (1998) S219-S221
45. Coffman R.L., Seimour B.W.P., Hudak S., Jackson J., and Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245 (1989) 308-310
46. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146 (1992) 374-377
47. Epstein M.M. Do mouse models of allergic asthma mimic clinical disease. Int. Arch. All. Clin. Immunol. 133 (2004) 84-100